These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10416269)

  • 1. Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.
    Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW
    Toxicol Sci; 1999 Jun; 49(2):241-54. PubMed ID: 10416269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical analysis of skin tumor data from Tg.AC mouse bioassays.
    Dunson DB; Haseman JK; van Birgelen AP; Stasiewicz S; Tennant RW
    Toxicol Sci; 2000 Jun; 55(2):293-302. PubMed ID: 10828260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors.
    Holden HE; Stoll RE; Spalding JW; Tennant RW
    J Appl Toxicol; 1998; 18(1):19-24. PubMed ID: 9526830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
    Spalding JW; Momma J; Elwell MR; Tennant RW
    Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model.
    Tennant RW; Stasiewicz S; Eastin WC; Mennear JH; Spalding JW
    Toxicol Pathol; 2001; 29 Suppl():51-9. PubMed ID: 11695562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene.
    Blanchard KT; Ball DJ; Holden HE; Furst SM; Stoltz JH; Stoll RE
    Toxicol Pathol; 1998; 26(4):541-7. PubMed ID: 9715513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogens.
    Holden HE; Stoll RE; Blanchard KT
    Toxicol Pathol; 1999; 27(5):507-12. PubMed ID: 10528629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tg.AC genetically altered mouse: assay working group overview of available data.
    Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
    Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
    Trempus CS; Haseman JK; Tennant RW
    Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA; Spalding JW; French JE; Tennant RW
    Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
    Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
    Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions.
    Sistare FD; Thompson KL; Honchel R; DeGeorge J
    Int J Toxicol; 2002; 21(1):65-79. PubMed ID: 11936901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripropylene glycol diacrylate but not ethyl acrylate induces skin tumors in a twenty-week short-term tumorigenesis study in Tg.AC (v-Ha-ras) mice.
    Nylander-French LA; French JE
    Toxicol Pathol; 1998; 26(4):476-83. PubMed ID: 9715506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.
    Thompson KL; Rosenzweig BA; Sistare FD
    Toxicol Pathol; 1998; 26(4):548-55. PubMed ID: 9715514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens.
    Tennant RW; Spalding J; French JE
    Mutat Res; 1996 Sep; 365(1-3):119-27. PubMed ID: 8898993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dichloroacetic acid for carcinogenicity in genetically modified Tg.AC hemizygous and p53 haploinsufficient mice.
    Kissling GE; Malarkey DE; Vallant MK; Johnson JD; Hejtmancik MR; Herbert RA; Boorman GA
    Toxicol Sci; 2009 Jan; 107(1):19-26. PubMed ID: 18974089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
    Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.